MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple sclerosis(MS)"

  • MDS Virtual Congress 2020

    Transcutaneous spinal cord current stimulation modulate Reactive Oxygen Species (ROS) in multiple sclerosis patients

    S. Mrakic-Sposta, R. Ferrucci, S. Floro, F. Ruggiero, M. Vergari, S. Versace, S. Santoni, A. Vezzoli, M. Massei, M. Deriz, S. Marceglia, S. Barbieri, A. Priori (Milan, Italy)

    Objective: To investigate the effect of Transcutaneous spinal cord current stimulation (tsDCS) on oxidative stress in patients with multiple sclerosis (MS). Background: MS is a…
  • 2019 International Congress

    Classification of Neurorehabilitation treatments: Preliminary results of a Multicentre Italian Study

    T. Bowman, F. Mestanza Mattos, R. Russo, M. Boninsegna, F. Marazzini, A. Marianelli, E. Pelosin, M. Putzolu, C. Cosentino, M. Petrarca, F. Tirinelli, M. Tondinelli, F. Trecate, M. Budel, A. Turolla, M. Agostini, D. Munari, P. Pillastrini, M. Branchini, D. Lunedei, G. Sgubin, D. Cattaneo, S. Mezzarobba (Milano, Italy)

    Objective: To taxonomize the contents of neurorehabilitation programs and categorize goals and treatments provided to people with Parkinson Disease(PD) and Multiple Sclerosis(MS) to understand their…
  • 2019 International Congress

    Wearable versus marker-free technologies: does it matter for clinical gait analysis?

    K. Otte, D. Drebinger, H. Röhling, T. Vater, D. Kroneberg, M. Voigt, B. Kayser, S. Mansow-Model, AU. Brandt, F. Paul, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: To compare wearable sensor-based and marker-less 3D video-based gait analysis in two neurodegenerative disorders associated with gait dysfunction. Background: Quantitative gait analysis supports diagnosis…
  • 2019 International Congress

    Descriptive Presentation of MRI Findings in Multiple Sclerosis Patients with Tonic Spasm

    M. Salari, M. Etemadifar, SH. Ghourchian (Tehran, Islamic Republic of Iran)

    Objective: It may provide a better gathering of data for further Meta-analyses regarding factors associated with tonic spasm in MS. Background: The lower prevalence of…
  • 2019 International Congress

    The concept of a ‘long lesion’ in thalamic/Zona inserta DBS for MS tremor suppression

    S. Alusi, B. Hammersley, J. Somerset, P. Eldridge, J. Farah (Liverpool, United Kingdom)

    Objective: To look at whether DBS programming to create a long field of stimulation in the thalamus-zona inserta (ZI) area is more effective, than traditional…
  • 2018 International Congress

    MRI-guided Focused Ultrasound thalamotomy for Multiple Sclerosis-associated tremor: A case report

    B. Fernández-Rodríguez, D. Urso, M. Monje, JA. Pineda-Pardo, M. del Álamo, R. Blazquez-Navarro, F. Hernández-Fernández, L. Vela, F. Alonso-Frech, R. Martínez-Fernández, J. Obeso (Móstoles, Spain)

    Objective: To describe the effect of VIM thalamotomy by MRI-guided Focused Ultrasound (MRIgFUS) on Multiple Sclerosis (MS) tremor in a single patient. Background: Tremor is…
  • 2018 International Congress

    Longitudinal follow-up of dual-lead thalamic deep brain stimulation for patients with treatment refractory multiple sclerosis tremor

    B. Patel, R. Barmore, A. Elkouzi, P. Zeilman, X. Bai, L. Almeida, K. Foote, M. Okun (Gainesville, FL, USA)

    Objective: To report long-term outcome measurements of tremor control in patients with medically refractory multiple sclerosis tremor and dual lead thalamic deep brain stimulation. Background:…
  • 2018 International Congress

    Under three seconds: Objective speech markers of ataxia in Multiple Sclerosis

    G. Noffs, F. Boonstra, S. Kolbe, A. Evans, H. Butzkeuven, T. Perera, A. Walt, A. Vogel (Melbourne, Australia)

    Objective: To examine the relationship between objective markers of speech motor control, disease severity and ataxia. Background: Mild dysarthria is a common symptom of Multiple…
  • 2017 International Congress

    A case report: a primary progressive multiple sclerosis (PPMS) with adolescent-onset of progressive cerebellar ataxia

    S.-K. Yang, J.-J. Lin (Changhua county, Taiwan)

    Objective: To report a 26 year-old female with progressive cerebellar ataxia for 12 years diagnosed to have primary progressive multiple sclerosis (PPMS).  Background: Multiple sclerosis (MS) is a kind of CNS demyelinating disease. About 15% MS patients have a progressive course without a relapsing course. These patients are considered to have PPMS. It often presented a progressive neurological problem--such as lateralizing weakness, or numbness in the legs. Cerebellar ataxia as primary symptom is less frequent in PPMS and it's usually diagnosed in their 40-60 years at age. Here we present a case with adolescent-onset PPMS presenting progressive cerebellar ataxic syndrome. Methods: A 26 year-old female Taiwanese presented with 12 years of progressive ataxic gait. She denied relapses and remissions of symptoms. There were no mental decline, involuntary movements, muscle hypertrophy or abnormality in hearing or vision. She had no associated family history or consanguineous parents. Physical examination revealed dysarthria, dysmetria/intentional tremor and dysdiadochokinesia in four limbs and bilateral extensor plantar response. In addition, she had normal tendon reflexes, intact sensory function and negative Romberg test without parkinsonian features. Her gait was wide-based. Results: On investigation, CBC, lipid profile, LFT, chest X-ray, serum electrolytes, ECG, EEG and NCV showed normal results. VEP study were abnormal. The brain and cervical spine MRI showed no significant cerebellar atrophy or myelopathy. Instead, FLAIR-weighted imaging showed diffuse plaques in brainstem and cerebral white matters with a predilection for periventricular white matter with the major axes perpendicular to the ventricular surface (Dawson’s fingers). Besides, the CSF study revealed oligoclonal banding and elevation of IgG index. She had normal serum copper and ceruloplasmin levels and plasma very long-chain fatty acids (VLCFA) analysis. The genetic testing for spinocerebellar ataxia ( SCA1, 2, 3, 6, 7 and 17) is negative. In view of progressive ataxia with diffuse white matter lesions, a diagnosis of PPMS was made. Conclusions: PPMS can be a etiology in adolescent patient with progressive ataxic syndrome. Brain MRI is a better tool for detecting cerebral white matter lesions compared to CT in differential diagnosis of progressive ataxia. References:…
  • 2017 International Congress

    Movement Disorders secondary to Spinal Cord Demyelination: an Evolving Spectrum

    H. Abboud, H. Fernandez, X.X. Yu, M. Mealy, M. Levy, J. Cohen (Cleveland, OH, USA)

    Objective: To describe the spectrum of movement disorders that result from spinal cord demyelination. Background: Spinal movement disorders (SMDs) secondary to cord demyelination are not…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley